Navigation Links
Inovio Pharmaceuticals Closes $15.1 Million Offering of Common Stock and Warrants
Date:3/12/2013

II cervical dysplasia clinical study, which we are now targeting for the first quarter of 2014."

A shelf registration statement (File No. 333-176670) relating to these securities was filed with the Securities and Exchange Commission on September 2, 2011, which was declared effective on September 23, 2011. A prospectus supplement and accompanying prospectus relating to the offering was filed with the Securities and Exchange Commission on March 7, 2013. Copies of the prospectus supplement and accompanying prospectus relating to the offering may be obtained from Cowen and Company, LLC (c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY 11717, Attn: Prospectus Department, Phone: 631-274,2806, Fax 631-254-7140). An electronic copy of the prospectus supplement and accompany prospectus relating to the offering is available on the website of the Securities and Exchange Commission at www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of offers to buy any securities of Inovio, and shall not constitute an offer, solicitation or sale of any security in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Inovio Pharmaceuticals, Inc.

Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases. Its SynCon® vaccines are designed to provide universal protection against known as well as new unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio's proprietary electroporation delivery, have been shown in humans to generate best-in-class immune responses with a favorable safety profile. Inovio's clinical programs include phase II studies for cervical dysplasia, leukemia and hepatitis C virus and phase I s
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants
2. Inovio Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. Inovio Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
4. Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference
5. Inovios Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses
6. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
7. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
8. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- Celsion Corporation (NASDAQ: CLSN ), an oncology drug ... , Chairman, President and CEO, is scheduled to present ... July 8, 2015, at 4:15 p.m. Eastern Time. The conference ... at 119 W. 56th Street, New York ... the presentation will be available in the Events & ...
(Date:7/1/2015)... 2015 Radiant Insights announce that ... Concentrators Market Shares, Strategy, and Forecasts, Worldwide, 2015 ... growth as the aging population worldwide needs homecare oxygen ... where oxygen is able to improve the quality of ... become affordable and support a mobile lifestyle even while ...
(Date:7/1/2015)... -- New exchange plan enrollees spent less on medications ... same time a year ago, according to the third ... Exchange Pulse™ report, released today. When compared ... new exchange plan enrollees who used at least one ... of 2015. However, when evaluating exchange plan medication trends ...
Breaking Medicine Technology:Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ... announced today its unaudited third quarter financial results for ... Financial Highlights , Sales in the third ... $9.6 million, and year-to-date sales increased 47.2% to $35.7 ...
... YORK, Nov. 14, 2011 Reportlinker.com announces that a new ... Test-Volume-and-Sales-Forecasts-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic title=,The 2011 Occult Blood Testing Market: US, ... and Sales Fo r ... Japan Test Volume and ...
Cached Medicine Technology:Sinovac Reports Unaudited Third Quarter 2011 Financial Results 2Sinovac Reports Unaudited Third Quarter 2011 Financial Results 3Sinovac Reports Unaudited Third Quarter 2011 Financial Results 4Sinovac Reports Unaudited Third Quarter 2011 Financial Results 5Sinovac Reports Unaudited Third Quarter 2011 Financial Results 6Sinovac Reports Unaudited Third Quarter 2011 Financial Results 7Sinovac Reports Unaudited Third Quarter 2011 Financial Results 8Sinovac Reports Unaudited Third Quarter 2011 Financial Results 9Sinovac Reports Unaudited Third Quarter 2011 Financial Results 10Sinovac Reports Unaudited Third Quarter 2011 Financial Results 11Sinovac Reports Unaudited Third Quarter 2011 Financial Results 12Sinovac Reports Unaudited Third Quarter 2011 Financial Results 13Sinovac Reports Unaudited Third Quarter 2011 Financial Results 14Sinovac Reports Unaudited Third Quarter 2011 Financial Results 15Sinovac Reports Unaudited Third Quarter 2011 Financial Results 16Sinovac Reports Unaudited Third Quarter 2011 Financial Results 17Sinovac Reports Unaudited Third Quarter 2011 Financial Results 18Sinovac Reports Unaudited Third Quarter 2011 Financial Results 19Sinovac Reports Unaudited Third Quarter 2011 Financial Results 20The 2011 Occult Blood Testing Market: US, Europe, Japan 2The 2011 Occult Blood Testing Market: US, Europe, Japan 3The 2011 Occult Blood Testing Market: US, Europe, Japan 4The 2011 Occult Blood Testing Market: US, Europe, Japan 5
(Date:7/1/2015)... ... July 01, 2015 , ... A healthy eating ... chickens and eggs. Eating organic foods and products can help limit the exposure ... friendly than production chicken farming. Choosing home raised chickens and eggs that do ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... cancer enterprise of Hospital Corporation of America (HCA), as it further expands its ... announced today. , With this new partnership, OncLive’s editorial and marketing teams ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the widow ... on August 15-16th (MSG Keys’ birthday) in memory of her late husband and all ... and recipient of the Bronze Star Medal, died during a Special Forces training exercise ...
(Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. is ... released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the Health ... available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is a ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... law has just published a top ten list they hope will guide future ... Click here to read it now. , More than 450 mesothelioma ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2
... A group of researchers from Stanford have identified the nitric ... chemical events gradually resulting in the development of an embryo.He ... the sperm.// ,The research is based on the ... purple invertebrates found in the Pacific Ocean just a few ...
... flowing smoothly after angioplasty shows surprising success in early testing. ... the drug-coated stent. //In testing on 50 patients over 3 ... ,More than 2 million Americans undergo angioplasty annually, ... most of them if these promising results hold up in ...
... honey could prove effective in arresting the dental plaque ... New Zealand researcher will report at the American Association// ... enzyme in honey that produces hydrogen peroxide is the ... Dr. Peter C. Molan, associate professor of biochemistry at ...
... of Medicine have recently found that the brain's 'nose plug' ... stop smelling something, even though the odour is still there.// ... journal Science show that a protein called CNGA4 helps plug ... neurons is to detect smells and send that information to ...
... close to signing a deal to acquire the 51.5 per ... drugmaker Abbott Laboratories Inc. An industry source who declined to ... next few days to buy the stake in Abbott Laboratories ... officials from the company’s regional office in singapore will be ...
... heart surgery for patients in their mid-eighties and beyond ... for the elderly.// ,According to Dr. Todd Rosengart, ... heart surgery, if indicated, is safe and will improve ... of cardiac surgery at Southeastern Healthcare in Illinois. ...
Cached Medicine News:Health News:The route to fertilization, 2Health News:Heart Surgery Is Getting Safer for the Old 2
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
For the quantitative kinetic determination of amylase activity, using manual or automated procedures, in human serum and urine....
Intended for the quantitative determination of alphaamylase activity in serum. Single vial, dry powder reagent. Reaction: Kinetic. Wavelength: 405 nm. Linearity: 2000 U/L at 37C....
For the quantitative determination of Gamma-GT in serum. Kinetic Reaction measured at 405 nm. Linearity: 600 IU/L at 37C....
Medicine Products: